Skip to main content
logo
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
11.71
+0.31 (2.72%)
Aug 25, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
59.2244.6447.5421.251.54-
Revenue Growth
77.83%-6.09%123.69%1284.50%--
Gross Profit
55.5140.8844.3519.991.45-
Operating Income
-1.12-6.282.57-12.77-22.59-17.22
Net Income
-3.25-9.74-0.44-16.05-23.71-17.35
Earnings Per Share
-0.10-0.34-0.02-0.60-0.90-0.67
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
41.2536.7926.6313.2723.7721.1
Total Debt
--19.3430.9524.94.99
Net Cash (Debt)
41.2536.797.29-17.68-1.1316.11
Net Cash Growth
-404.36%----46.90%
Net Cash Per Share
1.291.290.27-0.67-0.040.62

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.04-12.4726.98-17.14-18.06-14.22
Free Cash Flow
-2.04-12.4726.98-17.14-18.06-14.22
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
93.73%91.57%93.30%94.08%94.40%-
Operating Margin
-1.90%-14.07%5.40%-60.09%-1471.60%-
Pretax Margin
-5.24%-21.58%-0.15%-75.50%-1544.89%-
Profit Margin
-5.49%-21.82%-0.92%-75.50%-1544.89%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
18.8715.8837.3690.856.326.32
PS Ratio
6.935.893.6514.25164.24-